GRI Bio Presents Data Supporting Innovative Pipeline of NKT
Data presented at the 7th Annual Antifibrotic Drug Development (AFDD) Summit Company’s lead program, GRI-0621, has demonstrated ability to inhibit the...
Source: globenewswire.com
Stay updated with breaking news from Differential Activation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Data presented at the 7th Annual Antifibrotic Drug Development (AFDD) Summit Company’s lead program, GRI-0621, has demonstrated ability to inhibit the...
Findings demonstrate that the number of NKT cells positively correlates with the number of airway macrophages in IPF patients GRI...
Rapidly advancing clinical pipeline across multiple high-value inflammatory, fibrotic and autoimmune diseasesOn track to launch a Phase 2a biomark...